Randomised phase II trial of ETS 2101 [dexanabinol] in patients with glioma

Trial Profile

Randomised phase II trial of ETS 2101 [dexanabinol] in patients with glioma

Planning
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2013

At a glance

  • Drugs Dexanabinol (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Sponsors e-Therapeutics
  • Most Recent Events

    • 13 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top